Free Newsletter
CDC to modernize VAERS
With the heat on to monitor the safety of vaccines, the CDC is calling for a new electronic system that can swiftly gather reports of adverse events from around the country. Right now 80 percent of the Vaccine Adverse Event Reporting System is paper-based, says the CDC, which plans to up its investment into research on vaccine safety. The VAERS gathers reports on adverse events from doctors, manufacturers and an array of other sources. And it was given credit for flagging safety problems associated with the RotaShield rotavirus vaccine, which was taken off of the market.
New IT could also provide a more efficient way to gather vaccine data from eight big managed care organizations, offering a real-time look at the adverse events triggered by new vaccines. And analysts note that an electronic system is necessary to monitor the growing number of vaccines on the market. There are currently 59 vaccines in use.
- read the report from Government Health IT
Related Articles:
Gardasil side effects prompt CDC study
SAE report triggers calls for FDA reform
Comments
Modernizing VAERS is very important to understanding just what populations are susceptible to vaccine injuries. Hopefully those physicians who define "safe" as "benefits outweigh risks" will be more forthcoming about honestly reporting injuries. (The dictionary defines "safe" as "without risk.")
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




